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Abstract
Introduction: Pyrenochaeta romeroi (P. romeroi) is a saprophytic fungus found in soil and plants. The fungal spores
can be introduced into deeper tissues by trauma. It causes eumycetoma, which affects skin and subcutaneous
tissues.
Case presentation: A 57-year-old South Asian man presented with a painless, nodular lesion (1 cm × 0.5 cm) on
the left knee. He had had a renal transplant eight months earlier for end-stage renal failure. The patient was on
tacrolimus, mycophenolate mofetil and prednisolone for immunosuppression. The lesion had progressed
dramatically (to 5 cm × 5 cm) despite antibiotic treatment. The size and location of the lesion was severely
affecting his quality of life, so an excision biopsy was performed. Nuclear ribosomal repeat-region sequencing
confirmed the causative organism as P. romeroi.A nin vitro antifungal susceptibility test demonstrated that P.
romeroi was sensitive to voriconazole. Following a successful surgical removal, voriconazole was continued orally
for two months.
Conclusion: To the best of our knowledge, we are reporting the first case of Eumycetoma caused by P. romeroi in
a renal transplant recipient. Physicians should be aware of this rare fungal disease in transplant recipients. We
recommend a combination of medical and surgical management in these immunosuppressed patients.
Introduction
Eumycetoma is a chronic, specific, granulomatous, fun-
gal disease involving cutaneous and subcutaneous tissue
[1]. Only four cases of P. romeroi infection have been
reported in the literature [2-5]. To the best of our
knowledge, this is the first case in a renal transplant
recipient. The majority of the reported cases of this dis-
ease have occurred between the latitudes of 15° south
and 30° north [6]. It is extremely rare in temperate mar-
ine climates and sub-arctic zones such as Europe.
Case presentation
A 57-year-old South Asian man presented with a pain-
less, nodular lesion (1 cm × 0.5 cm) on his left knee. He
had had a renal transplant eight months earlier for auto-
somal dominant polycystic kidney-related renal failure.
He received two doses (20 mg) of interleukin receptor-2
antibodies (Simulect
®, Novartis Pharmaceuticals, Surrey,
UK) at induction and on the fourth postoperative day.
This was followed by tacrolimus, mycophenolate mofetil
and prednisolone for immunosuppression. During the
follow-up period, his tacrolimus level was kept within
the therapeutic range (5 to 8 ng/ml). He was cytomega-
lovirus (CMV) negative and had received a kidney from
a CMV-negative deceased donor. He had immigrated to
the United Kingdom from Bangladesh twenty-five years
ago and had last visited there eight years ago. There was
no past history of trauma to the knee.
He was started on flucloxacillin and the course was
extended for a period of 14 days. In spite of antibiotic
therapy, the lesion progressed significantly and reached
5 cm × 5 cm (Figure 1) and became cystic in nature.
The lesion was confined to the skin and subcutaneous
tissue with no deep extension to bone or lymph node
involvement. The surface of the lesion had multiple
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was sent for microscopy.
During this period, he did not show any systemic
symptoms and inflammatory markers (C-reactive pro-
tein) and his white cell count were both normal.
Because of the failure of antibiotic therapy and the fast
growing nature of the lesion an incisional biopsy was
performed.
Histological examination of the specimen showed
marked epidermal hyperplasia and abundant fungal
spores with hyphae. The microscopy of the discharge
also confirmed the fungal spores and hyphae (fungal
grains).
The patient was started provisionally on voriconazole
while awaiting confirmation of the causative organism.
The large size of the lesion on his knee significantly
reduced his quality of life so an excision biopsy was
done. The specimen showed marked epidermal hyper-
plasia with microabscess formation. Within the micro-
abscess, there were PAS (Periodic acid-Schiff) positive
branching and septate hyphae (Figure 2). No bacteria
were found. The excision margins were clear, and no
evidence of the neoplastic process was found.
Nuclear ribosomal repeat-region sequencing con-
firmed that the causative organism was P. romeroi
(Mycology Reference Laboratory, Bristol, UK). An in
vitro antifungal susceptibility test demonstrated that P.
romeroi was sensitive to voriconazole. Following a suc-
cessful surgical removal, voriconazole was continued
orally for two months under the care of the infectious-
disease team. No recurrence was seen during the follow-
ing six months.
Discussion
Eumycetoma can cause skin and deep-tissue involve-
ment and may result in the need for an amputation [6].
P. romeroi is a saprophytic fungus found in soil and
plants that can be introduced into deeper tissues by
trauma [7]. A typical case of eumycetoma usually pre-
sents in exposed areas of the body but it is not uncom-
mon in unexposed areas. The exact reason for infection
in unexposed areas is unknown but it may be related to
the bacterial count and moist skin [8]. P. romeroi and P.
mackinnonni have been isolated from clinical material
obtained from patients with mycetoma [9,10]. The
lesions were found to develop slowly following trauma
and they were usually localized to cutaneous and subcu-
taneous tissues [11].
The identification of this organism was difficult
because of the inability of some strains to readily pro-
duce characteristic diagnostic structures in cultures and
also because of a lack of expertise in diagnostic micro-
biology laboratories. Young et al. [12] reported a similar
case in a transplant recipient but the histopathological
appearance of this lesion was closely similar to those
caused by Exophiala jeanselmei or Phialophora richard-
siae. Microscopy showed dematiaceous hyphae with
yeast-like cells and the diagnosis was a phoma-like spe-
cies resembling P. romeroi.
Girard et al.[ 3 ]r e p o r t e daP. romeroi infection in a
leprosy patient but to the best of our knowledge our
patient is the first confirmed case in an immunocom-
promised renal transplant recipient. Our case was
reported during the eight months after transplant. The
immunosuppression was achieved with tacrolimus (ther-
apeutic level maintained at 5 to 8 ng/ml), mycopheno-
late mofetil and prednisolone at the time of diagnosis.
The immunosuppressive therapy was within the unit
protocol, and he never had any viral infection during
this period. Although the infection can be coincidental,
previous cases have been reported mostly in immuno-
compromised patients. In our patient, the role of the
immunosuppressive burden was likely to be a
Figure 1 Cystic lesion on the left knee.
Figure 2 PAS positive branching and septate hyphae on
histology.
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thorough examination to avoid further morbidity and
mortality.
Because these organisms are seen in tropical/sub-tro-
p i c a lc o u n t r i e s ,w ec a n n o te x p l a i nt h ep o s s i b l es o u r c e
and mode of transmission of P. romeroi to our patient.
The spores may have been introduced in the past and
remained dormant until he was started on immunosup-
pression. This theory of the dormant nature of spores is
also supported by another case report where the infec-
tion developed three years after immunosuppression was
started for leukemia [5]. Hence, it is important to note
any history of immigration and foreign travel.
The literature shows that from a treatment point of
view, surgical treatment is usually successful because no
standardized therapy is available [13]. The literature also
suggests that antifungal susceptibility of Pyrenochaeta
species is scanty due to low availability and the low
number of clinical isolates [2,4].
P. romeroi has been shown to be resistant to broad-
spectrum antifungals such as amphotercin B, flucona-
zole, itraconazole and caspofungin [2,4]. Khan et al.[ 5 ]
reported that P. romeroi is sensitive to voriconazole and
posaconazole and a similar susceptibility was found in
our case. The treatment should be tailored according to
the location and size of the lesion. In areas over joints
and bones, it is worth combining surgical and antifungal
treatments. This can be curative and can prevent early
deep-tissue involvement.
Khan et al. [5] have reported a single case of subcuta-
neous infection in a patient with acute lymphoid leuke-
mia (ALL) who was successfully treated with surgical
excision and required no medical management. Other
reports [2,4,14] suggest using surgical debridement fol-
lowed by prolonged use of triazole, which we also feel is
reasonable because it reduces the risk of disseminated
infection in immunosuppression.
Conclusions
It is imperative to consider a fungal etiology when an
infection is not responding to antibiotics in post-trans-
plant patients, even if the patient is living in a geogra-
phical area where this fungus is uncommon. Early
diagnosis can be made by incision biopsy, but surgical
excision should be considered if the infection is over the
bone or joints. We recommend a combination of surgi-
cal and extended antifungal treatment in post-transplant
immunosuppressed patients to prevent invasive disease.
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